Anti-Bak 抗体 [Y164]
Anti-Bak antibody [Y164]
- BOND RX™ Validated
- 20ul selling size
- RabMAb
- Recombinant
- KO Validated
- 詳細を見る
5
(3 Reviews)
|
(73 Publications)
Knockout Tested Rabbit Recombinant Monoclonal BAK antibody. Suitable for IP, WB, Flow Cyt (Intra), IHC-P and reacts with Human samples. Cited in 73 publications.
別名を表示する
BAK, BCL2L7, CDN1, BAK1, Bcl-2 homologous antagonist/killer, Apoptosis regulator BAK, Bcl-2-like protein 7, Bcl2-L-7
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bak antibody [Y164] (AB32371)
Immunohistochemical analysis of Bak expression in paraffin embedded human stomach carcinoma, using 1/250 unpurified ab32371.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bak antibody [Y164] (AB32371)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human pancreatic carcinoma tissue sections labeling Bak with Purified ab32371 at 1 : 200 dilution (2.98 μg/ml). Heat mediated antigen retrieval was performed using ab93684 (Tris/EDTA buffer, pH 9.0). Tissue was counterstained with Hematoxylin. ab97051 Goat Anti-Rabbit IgG H&L (HRP)
secondary antibody was used at 1 : 500 dilution. PBS instead of the primary antibody was used as the negative control.
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-Bak antibody [Y164] (AB32371)
Flow cytometric analysis of 4% paraformaldehyde fixed, 90% methanol permeabilized BAK1 KO Hela (human BAK1 knockout cervical adenocarcinoma epithelial cell, Left) /Parental Hela (Right) cells labelling Bak with ab32371 at 1/500 dilution (0.1 µg)(Red) compared with a Rabbit monoclonal IgG (ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). Goat Anti-Rabbit IgG (Alexa Fluor® 488, ab150081) at 1/5000 dilution was used as the secondary antibody.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bak antibody [Y164] (AB32371)
Immunohistochemical analysis of paraffin-embedded fixed (A) Wild-type HeLa (human cervix adenocarcinoma epithelial cell) cell pellet. (B) BAK1 knockout HeLa (ab265277) cell pellet staining Bak with ab32371 at 1/2000 dilution followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). Counter-staining used was hematoxylin. Positive staining on (A) Wild-type HeLa cell pellet, no staining on (B) BAK1 knockout HeLa (ab265277) cell pellet. The section was incubated with ab32371 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Bak antibody [Y164] (AB32371)
Immunocytochemistry/ Immunofluorescence analysis of HeLa (Human cervix adenocarcinoma epithelial cell) cells labeling Bak with Purified ab32371 at 1 : 100 dilution. Cells were fixed in 4% Paraformaldehyde and permeabilized with 0.1% tritonX-100. Cells were counterstained with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) 1 : 200. ab150077 Goat anti rabbit IgG(Alexa Fluor® 488) was used as the secondary antibody at 1 : 1000 dilution. DAPI nuclear counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Bak antibody [Y164] (AB32371)
ICC/IF image of unpurified ab32371 stained HeLa cells. The cells were 4% PFA fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (unpurified ab32371, 1μg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-rabbit IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43μM.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bak antibody [Y164] (AB32371)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human stomach tissue sections labeling Bak with Purified ab32371 at 1 : 200 dilution (2.98 μg/ml). Heat mediated antigen retrieval was performed using ab93684 (Tris/EDTA buffer, pH 9.0). Tissue was counterstained with Hematoxylin. ab97051 Goat Anti-Rabbit IgG H&L (HRP)
secondary antibody was used at 1 : 500 dilution. PBS instead of the primary antibody was used as the negative control.
- IP
Lab
Immunoprecipitation - Anti-Bak antibody [Y164] (AB32371)
ab32371 (purified) at 1 : 20 dilution (2μg) immunoprecipitating Bak in HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate.
Lane 1 (input) : HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate 10μg
Lane 2 (+) : ab32371 & HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab32371 in HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate
For western blotting, VeriBlot for IP Detection Reagent (HRP) (ab131366) was used for detection at 1 : 1000 dilution.
Blocking and diluting buffer : 5% NFDM/TBST.
All lanes:
Immunoprecipitation - Anti-Bak antibody [Y164] (ab32371)
Predicted band size: 23 kDa
false
- IP
AbReview37813****
Immunoprecipitation - Anti-Bak antibody [Y164] (AB32371)
Bak was immunoprecipitated from HCT116 p53-/- cell line whole cell lysate with unpurified ab32371 at 1/100 dilution.
Western blot was performed from the immunoprecipitate using ab32371 at 1/2000 dilution.
All lanes:
Immunoprecipitation - Anti-Bak antibody [Y164] (ab32371)
Predicted band size: 23 kDa
false
- WB
Lab
Western blot - Anti-Bak antibody [Y164] (AB32371)
Lanes 1- 2 : Merged signal (red and green). Green - ab32371 observed at 23 kDa. Red - Anti-GAPDH antibody [6C5] - Loading Control (ab8245) observed at 37 kDa.
ab32371 was shown to react with Bak in wild-type HeLa cells in western blot. Loss of signal was observed when knockout cell line ab265277 (knockout cell lysate ab257077) was used. Wild-type HeLa and BAK1 knockout HeLa cell lysates were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab32371 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-Bak antibody [Y164] (ab32371) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
BAK1 knockout HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human BAK1 (Bak) knockout HeLa cell line (<a href='/products/cell-lines/human-bak1-bak-knockout-hela-cell-line-ab265277'>ab265277</a>)
Predicted band size: 23 kDa
Observed band size: 23 kDa
false
- WB
Lab
Western blot - Anti-Bak antibody [Y164] (AB32371)
Lanes 1 - 3 : Merged signal (red and green). Green - ab32371 observed at 25 kDa. Red - loading control, ab9484, observed at 37 kDa.
Unpurified ab32371 was shown to specifically recognize BAK in wild-type HAP1 cells. No band was observed when BAK knockout cells were examined. Wild-type and BAK knockout samples were subjected to SDS-PAGE. Unpurified ab32371 and ab9484 (Mouse anti GAPDH loading control) were incubated overnight at 4°C at 1/1000 dilution and 1/20,000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/20,000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-Bak antibody [Y164] (ab32371)
Lane 1:
Wild-type HAP1 whole cell lysate at 20 µg
Lane 2:
BAK knockout HAP1 whole cell lysate at 20 µg
Lane 3:
Human Heart whole cell lysate at 20 µg
Predicted band size: 23 kDa
false
- WB
Lab
Western blot - Anti-Bak antibody [Y164] (AB32371)
Blocking and diluting buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-Bak antibody [Y164] (ab32371) at 1/10000 dilution
Lane 1:
HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysates at 20 µg
Lane 2:
HEK-293 (Human embryonic kidney epithelial cell) whole cell lysates at 20 µg
Lane 3:
Human fetal heart lysates at 20 µg
Secondary
All lanes:
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/2000 dilution
Predicted band size: 23 kDa
Observed band size: 23 kDa
false
- WB
Unknown
Western blot - Anti-Bak antibody [Y164] (AB32371)
All lanes:
Western blot - Anti-Bak antibody [Y164] (ab32371) at 1/5000 dilution
All lanes:
HeLa cell lysate
Predicted band size: 23 kDa
Observed band size: 23 kDa
false
- WB
CiteAb
Western blot - Anti-Bak antibody [Y164] (AB32371)
Bak western blot using anti-Bak antibody [Y164] ab32371. Publication image and figure legend from Paolini, F., Zaccarini, M., et al., 2020, Front Cell Infect Microbiol, PubMed 32257968.
ab32371 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab32371 please see the product overview.
HPV15 affects TNF-α-induced apoptosis. HaCaT (A) and HPK (B) cells were utlized. HPV 15 transduction, IKKγ gene silencing and TNF-α treatment (10 ng/ml) for 6 h are indicated. Apoptosis was measured by a Cell Death ELISA test according to manufacturer's instruction in triplicate samples. Error bars = ±SD. ***p < 0.0001 by unpaired t-test. Activation of apoptotic pathway was analyzed in cell lysates by Western blots with anti-cleaved Caspase 3 or anti-BAK antibodies, as described in section Materials and Methods. All these experiments were repeated twice with similar results.
false
関連する標識済み抗体及び組成の異なる製品 (2)
-
HRP Anti-Bak antibody [Y164]
-
Anti-Bak antibody [Y164] - BSA and Azide free
Reactivity data
製品の詳細
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Bak engages in promoting apoptosis by disrupting the mitochondrial outer membrane potential. It is part of the Bcl-2 family complex which balances cell survival and cell death. Bak collaborates with Bax protein to form pores in the mitochondrial membrane releasing cytochrome c and other apoptotic factors. This process initiates the cascade of caspases leading to programmed cell death.
Pathways
Bak is a critical component of the intrinsic apoptotic pathway. It directly interacts with pro-apoptotic proteins like Bax and anti-apoptotic proteins such as Bcl-2 and Bcl-xL. Bak's action in the apoptotic pathway involves a delicate balance between survival and death signals affecting cellular homeostasis. In addition Bak's interaction with the p53 pathway emphasizes its role in response to DNA damage ensuring damaged cells do not proliferate uncontrollably.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (73)
Recent publications for all applications. Explore the full list and refine your search
The Journal of biological chemistry 301:108421 PubMed40113041
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature biomedical engineering 8:1379-1395 PubMed39025942
2024
Applications
Unspecified application
Species
Unspecified reactive species
Communications medicine 3:154 PubMed37880389
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cancers 15: PubMed37509312
2023
Applications
Unspecified application
Species
Unspecified reactive species
Immunity, inflammation and disease 11:e958 PubMed37506141
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of advanced research 60:201-214 PubMed37467961
2023
Applications
Unspecified application
Species
Unspecified reactive species
Hereditas 160:30 PubMed37464443
2023
Applications
Unspecified application
Species
Unspecified reactive species
Discover. Oncology 14:28 PubMed36853387
2023
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine (Cambridge, Mass.) 29:10 PubMed36658493
2023
Applications
Unspecified application
Species
Unspecified reactive species
Anti-cancer drugs 34:15-28 PubMed36206143
2022
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com